Product NDC: | 76204-100 |
Proprietary Name: | Ipratropium Bromide |
Non Proprietary Name: | Ipratropium Bromide |
Active Ingredient(s): | .5 mg/2.5mL & nbsp; Ipratropium Bromide |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76204-100 |
Labeler Name: | Ritedose Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075693 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110201 |
Package NDC: | 76204-100-30 |
Package Description: | 1 POUCH in 1 CARTON (76204-100-30) > 30 AMPULE in 1 POUCH > 2.5 mL in 1 AMPULE |
NDC Code | 76204-100-30 |
Proprietary Name | Ipratropium Bromide |
Package Description | 1 POUCH in 1 CARTON (76204-100-30) > 30 AMPULE in 1 POUCH > 2.5 mL in 1 AMPULE |
Product NDC | 76204-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ipratropium Bromide |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20110201 |
Marketing Category Name | ANDA |
Labeler Name | Ritedose Pharmaceuticals, LLC |
Substance Name | IPRATROPIUM BROMIDE |
Strength Number | .5 |
Strength Unit | mg/2.5mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |